News & Updates
•
August 18, 2017
Two pre-grant oppositions filed by Panacea Biotech and Medecins Sans Frontieres (MSF) have been dismissed and a patent has been granted in favour of Wyeth for Prevnar 13.
Published on Patents Rewind.